Search research articles
Contact Us
Filters
Showing results (181-190 of 208) with videos related to
Page
of 21
Sort By:
European Urology
|
May 17, 2023
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
Ibrahim Jubber, Sean Ong, Laura Bukavina, et al.
European Urology Oncology
|
April 22, 2023
Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314
Yi-Tsung Lu, Melissa Plets, Gareth Morrison, et al.
Nature Reviews. Urology
|
September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
Lexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
Genome Biology
|
April 16, 2021
Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer
Tejaswi Iyyanki, Baozhen Zhang, Qixuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2023
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Seth P Lerner, David J McConkey, Catherine M Tangen, et al.
Nature Communications
|
April 27, 2023
Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer
A Gordon Robertson, Khyati Meghani, Lauren Folgosa Cooley, et al.
European Urology
|
July 21, 2020
Identification of Differential Tumor Subtypes of T1 Bladder Cancer
A Gordon Robertson, Clarice S Groeneveld, Brian Jordan, et al.
European Urology
|
November 21, 2021
Corrigendum to "Identification of Differential Tumor Subtypes of T1 Bladder Cancer" [Eur. Urol. 78 (2020) 533-537]
A Gordon Robertson, Clarice S Groeneveld, Brian Jordan, et al.
NPJ Digital Medicine
|
March 23, 2025
Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning
Zilong Bai, Mohamed Osman, Matthew Brendel, et al.
Nature Medicine
|
May 23, 2018
Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy
Lu Wang, Zibo Zhao, Patrick A Ozark, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 208) with videos related to
Sort By:
Page
of 21
European Urology
|
May 17, 2023
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
Ibrahim Jubber, Sean Ong, Laura Bukavina, et al.
European Urology Oncology
|
April 22, 2023
Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314
Yi-Tsung Lu, Melissa Plets, Gareth Morrison, et al.
Nature Reviews. Urology
|
September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
Lexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
Genome Biology
|
April 16, 2021
Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer
Tejaswi Iyyanki, Baozhen Zhang, Qixuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2023
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Seth P Lerner, David J McConkey, Catherine M Tangen, et al.
Nature Communications
|
April 27, 2023
Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer
A Gordon Robertson, Khyati Meghani, Lauren Folgosa Cooley, et al.
European Urology
|
July 21, 2020
Identification of Differential Tumor Subtypes of T1 Bladder Cancer
A Gordon Robertson, Clarice S Groeneveld, Brian Jordan, et al.
European Urology
|
November 21, 2021
Corrigendum to "Identification of Differential Tumor Subtypes of T1 Bladder Cancer" [Eur. Urol. 78 (2020) 533-537]
A Gordon Robertson, Clarice S Groeneveld, Brian Jordan, et al.
NPJ Digital Medicine
|
March 23, 2025
Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning
Zilong Bai, Mohamed Osman, Matthew Brendel, et al.
Nature Medicine
|
May 23, 2018
Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy
Lu Wang, Zibo Zhao, Patrick A Ozark, et al.
Page
of 21